1 |
Kox, W.J., Volk, T., Kox, S.N. and Volk, H.D. (2000) Immunomodulatory therapies in sepsis. Intensive Care Med., 26, S124-S128.
|
2 |
Boutagy, N.E., McMillan, R.P., Frisard, M.I. and Hulver, M.W. (2016) Metabolic endotoxemia with obesity: is it real and is it relevant? Biochimie, 124, 11-20.
DOI
|
3 |
Hietbrink, F., Besselink, M.G., Renooij, W., de Smet, M.B., Draisma, A., van der Hoeven, H. and Pickkers, P. (2009) Systemic inflammation increases intestinal permeability during experimental human endotoxemia. Shock, 32, 374-378.
|
4 |
Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F., Tuohy, K.M. and Chabo, C. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56, 1761-1772.
DOI
|
5 |
Tarasenko, T.N. and McGuire, P.J. (2017) The liver is a metabolic and immunologic organ: a reconsideration of metabolic decompensation due to infection in inborn errors of metabolism (IEM). Mol. Genet. Metab., 121, 283-288.
|
6 |
Dhainaut, J.F., Marin, N., Mignon, A. and Vinsonneau, C. (2001) Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit. Care Med., 29, S42-S47.
DOI
|
7 |
Maitra, U., Gan, L., Chang, S. and Li, L. (2011) Low-dose endotoxin induces inflammation by selectively removing nuclear receptors and activating CCAAT/enhancer-binding protein . J. Immunol., 186, 4467-4473.
DOI
|
8 |
Aggarwal, N.R., Tsushima, K., Eto, Y., Tripathi, A., Mandke, P., Mock, J.R., Garibaldi, B.T., Singer, B.D., Sidhaye, V.K., Horton, M.R., King, L.S. and D'Alessio, F.R. (2014) Immunological priming requires regulatory T cells and IL-10-producing macrophages to accelerate resolution from severe lung inflammation. J. Immunol., 192, 4453-4464.
DOI
|
9 |
Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E. and Ridker, P.M. (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 286, 327-334.
|
10 |
Zhou, F., Ciric, B., Li, H., Yan, Y., Li, K., Cullimore, M., Lauretti, E., Gonnella, P., Zhang, G.X. and Rostami, A. (2012) IL-10 deficiency blocks the ability of LPS to regulate expression of tolerance-related molecules on dendritic cells. Eur. J. Immunol., 42, 1449-1458.
DOI
|
11 |
Kalinski, P. (2012) Regulation of immune responses by prostaglandin E2. J. Immunol., 188, 21-28.
DOI
|
12 |
Fernando, L.P., Fernando, A.N., Ferlito, M., Halushka, P.V. and Cook, J.A. (2000) Suppression of Cox-2 and TNF-alpha mRNA in endotoxin tolerance: effect of cycloheximide, antinomycin D, and okadaic acid. Shock, 14, 128-133.
DOI
|
13 |
Ando, K. and Fujita, T. (2009) Metabolic syndrome and oxidative stress. Free Radic. Biol. Med., 47, 213-218.
DOI
|
14 |
Hotamisligil, G.S. (2006) Inflammation and metabolic disorders. Nature, 444, 860-867.
DOI
|
15 |
Kumar, S. and Adhikari, A. (2017) Dose-dependent immunomodulating effects of endotoxin in allergic airway inflammation. Innate Immun., 23, 249-257.
DOI
|
16 |
Matsushita, H., Ohta, S., Shiraishi, H., Suzuki, S., Arima, K., Toda, S., Tanaka, H., Nagai, H., Kimoto, M., Inokuchi, A. and Izuhara, K. (2010) Endotoxin tolerance attenuates airway allergic inflammation in model mice by suppression of the T-cell stimulatory effect of dendritic cells. Int. Immunol., 22, 739-747.
|
17 |
Chae, B.S. (2002) Comparative study of the endotoxemia and endotoxin tolerance on the production of Th cytokines and macrophage interleukin-6: differential regulation of indomethacin. Arch. Pharm. Res., 25, 910-916.
DOI
|
18 |
Saad, B., Frei, K., Scholl, F.A., Fontana, A. and Maier, P. (1995) Hepatocyte-derived interleukin-6 and tumor-necrosis factor alpha mediate the lipopolysaccharide-induced acutephase response and nitric oxide release by cultured rat hepatocytes. Eur. J. Biochem., 229, 349-355.
DOI
|
19 |
Poujol, F., Monneret, G., Gallet-Gorius, E., Pachot, A., Textoris, J. and Venet, F. (2017) Ex vivo Stimulation of Lymphocytes with IL-10 mimics sepsis-induced intrinsic T-cell alterations. Immunol. Invest., 28, 1-15.
|
20 |
Bauer, M., Press, A.T. and Trauner, M. (2013) The liver in sepsis: patterns of response and injury. Curr. Opin. Crit. Care., 19, 123-127.
|
21 |
Panesar, N., Tolman, K. and Mazuski, J. E. (1999) Endotoxin stimulates hepatocyte interleukin-6 production. J. Surg. Res., 85, 251-258.
DOI
|
22 |
Mohamed, J., Nazratun Nafizah, A.H., Zariyantey, A.H. and Budin, S.B. (2016) Mechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammation. J. Sultan Qaboos Univ. Med., 16, e132-e141.
DOI
|
23 |
Nakasone, M., Nakaso, K., Horikoshi, Y., Hanaki, T., Kitagawa, Y., Takahashi, T., Inagaki, Y. and Matsura, T. (2016) Preconditioning by low dose LPS prevents subsequent LPS-induced severe liver injury via Nrf2 activation in mice. Yonago Acta Med., 59, 223-231.
|
24 |
Dupuy, A.M., Terrier, N., Senecal, L., Morena, M., Leray, H., Canaud, B. and Cristol, J.P. (2003) Is C-reactive protein a marker of inflammation? Nephrologie, 24, 337-341.
|
25 |
Ridker, P.M. and Morrow, D.A. (2003) C-reactive protein, inflammation, and coronary risk. Cardiol. Clin., 21, 315-325.
DOI
|
26 |
Offenbacher, S. and Salvi, G.E. (1999) Induction of prostaglandin release from macrophages by bacterial endotoxin. Clin. Infect. Dis., 28, 505-513.
DOI
|
27 |
Kramer, F., Torzewski, J., Kamenz, J., Veit, K., Hombach, V., Dedio, J. and Ivashchenko, Y. (2008) Interleukin-1beta stimulates acute phase response and C-reactive protein synthesis by inducing an NFkappaB- and C/EBPbeta-dependent autocrine interleukin-6 loop. Mol. Immunol., 45, 2678-2689.
DOI
|
28 |
Heymann, F. and Tacke, F. (2016) Immunology in the liver--from homeostasis to disease. Nat. Rev. Gastroenterol. Hepatol., 13, 88-110.
|
29 |
Alexander, C. and Rietschel, E.T. (2001) Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res., 7, 167-202.
|
30 |
Patel, P.N., Shah, R.Y., Ferguson, J.F. and Reilly, M.P. (2015) Human experimental endotoxemia in modeling the pathophysiology, genomics, and therapeutics of innate immunity in complex cardiometabolic diseases. Arterioscler. Thromb. Vasc. Biol., 35, 525-534.
|
31 |
Kawai, T. and Akira, S. (2007) Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med., 13, 460-469.
DOI
|
32 |
Maitra, U., Gan, L., Chang, S. and Li, L. (2011) Low-dose endotoxin induces inflammation by selectively removing nuclear receptors and activating CCAAT/enhancer-binding protein . J. Immunol., 186, 4467-4473.
DOI
|
33 |
Biswas, S.K. and Lopez-Collazo, E. (2009) Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol., 30, 475-487.
DOI
|
34 |
Cheng, S.C., Scicluna, B.P., Arts, R.J., Gresnigt, M.S., Lachmandas, E., Giamarellos-Bourboulis, E.J., Kox, M., Manjeri, G.R., Wagenaars, J.A., Cremer, O.L., Leentjens, J., van der Meer, A.J., van de Veerdonk, F.L., Bonten, M.J., Schultz, M.J., Willems, P.H., Pickkers, P., Joosten, L.A., van der Poll, T. and Netea, M.G. (2016) Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat. Immunol., 17, 406-413.
DOI
|
35 |
Deng, H., Maitra, U., Morris, M. and Li, L. (2013) Molecular mechanism responsible for the priming of macrophage activation. J. Biol. Chem., 288, 3897-3906.
|
36 |
Chen, K., Geng, S., Yuan, R., Diao, N., Upchurch, Z. and Li, L. (2015) Super-low dose endotoxin pre-conditioning exacerbates sepsis mortality. EBioMedicine, 2, 324-333.
|
37 |
Morris, M. and Li, L. (2012) Molecular mechanisms and pathological consequences of endotoxin tolerance and priming. Arch. Immunol. Ther. Exp. (Warsz), 60, 13-18.
DOI
|
38 |
Romagnani, S. (2000) T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol., 85, 9-18.
DOI
|
39 |
Balkhy, H.H. and Heinzel, F.P. (1999) Endotoxin fails to induce IFN-gamma in endotoxin-tolerant mice: deficiencies in both IL-12 heterodimer production and IL-12 responsiveness. J. Immunol., 162, 3633-3638.
|
40 |
Heinzel, F.P. (1990) The role of IFN-gamma in the pathology of experimental endotoxemia. J. Immunol., 145, 2920-2924.
|